CBI’s Financial Strategies and Accounting for Bioscience Companies

As more life science companies prepare to launch new products and drive growth, senior-level finance and accounting professionals are shouldering greater responsibilities, with higher expectations from stakeholders. CBI’s Financial Strategies and Accounting for Bioscience Companies is tailored to the distinctive business needs and technical accounting challenges for small-middle market biotech, pharmaceutical and device companies. During this CPE accredited event Finance and Accounting executives gain pre-revenue commercialization strategies, frameworks for managing gross-to-net estimates and mitigating risk, models to scale and grow a best-in-class finance function, timely updates on tax and legal matters, and industry expertise for communications and investor relations.

Download the agenda and learn more at www.cbinet.com/financialstrategies.